logo
Appeals Court Paves Way for Mass Layoffs at C.F.P.B.

Appeals Court Paves Way for Mass Layoffs at C.F.P.B.

New York Times12 hours ago
A federal appeals court paved the way for the Trump administration to move ahead with plans to decimate the Consumer Financial Protection Bureau, ruling 2 to 1 to throw out a lower court's effort to block mass layoffs.
In the 49-page ruling, Judge Gregory G. Katsas of the U.S. Court of Appeals for the District of Columbia Circuit, a Trump appointee, wrote that Judge Amy Berman Jackson of the Federal District Court in Washington had no jurisdiction to block the Trump administration's efforts to lay off about 1,500 of the C.F.P.B.'s 1,700 workers.
Civil servants' employment-related complaints are subject under law to a specialized review process, he wrote, and the plaintiffs' other grievances did not pertain to reviewable, final agency actions or unconstitutional acts.
'Accordingly, we vacate the preliminary injunctions,' Judge Katsas wrote in the majority decision, in which he was joined by Judge Neomi Rao, also a Trump appointee.
But the effect of the ruling is not expected for at least seven days, leaving the plaintiffs time to appeal.
This spring, the Trump administration attempted to reduce the C.F.P.B.'s work force by nearly 90 percent, a move blocked by Judge Jackson. Over the next several weeks, a frenetic back-and-forth ensued, as the three-judge panel from the U.S. Court of Appeals for the District of Columbia Circuit overturned Judge Jackson's initial injunction before allowing a revised version to stand until they could fully address the matter.
The C.F.P.B., an Obama-era creation that was the brainchild of Senator Elizabeth Warren, Democrat of Massachusetts, has long been a target of President Trump, and was a focal point for his so-called Department of Government Efficiency, a federal cost-cutting operation led by the tech billionaire Elon Musk.
Less than three weeks into Mr. Trump's second term, Russell T. Vought, the director of the Office of Management and Budget who was also named acting director of the C.F.P.B., ordered the agency's employees to cease 'all supervision and examination activity,' effectively freezing their operations. The layoff notices came almost immediately after.
Congress created the C.F.P.B. in 2010, as part of a wider financial regulatory overhaul, and the plaintiffs argued that the Trump administration's efforts to diminish it were an unlawful power grab from the legislative branch. The appeals court's ruling disputed their argument that the administration's moves to drastically reduce the agency's staff were a final decision about the fate of the agency.
In a dissent published Friday, Judge Cornelia T.L. Pillard, an Obama appointee, rejected her colleagues' view, stating that only Congress could dissolve the agency.
'It is emphatically not within the discretion of the president or his appointees to decide that the country would benefit most if there were no bureau at all,' she wrote in a 60-page dissent.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Starmer speaks with Trump after president's Ukraine ceasefire talks with Putin
Starmer speaks with Trump after president's Ukraine ceasefire talks with Putin

Yahoo

time17 minutes ago

  • Yahoo

Starmer speaks with Trump after president's Ukraine ceasefire talks with Putin

Sir Keir Starmer has spoken with Donald Trump after the US president's summit with Vladimir Putin ended without a deal to stop the war in Ukraine. The Prime Minister joined a call with Mr Trump and Ukraine's Volodymyr Zelensky, as well as other European leaders, after the US-Russia ceasefire talks, Downing Street said. Mr Trump did not secure a deal to end the conflict in Ukraine after nearly three hours of talks with his Russian counterpart at a military base in Anchorage, Alaska. After the negotiations, which took place alongside senior officials, the two presidents refused to answer questions from reporters. However, both made statements, with Mr Trump saying 'some great progress' was made with 'many points' agreed and 'very few' remaining. In a call after the summit, Sir Keir and Mr Zelensky spoke with the US president alongside leaders from Italy, France, Finland, Germany and Poland, as well as Nato's Mark Rutte, and Ursula von der Leyen of the European Commission. Sir Keir is due to speak again with European leaders this morning.

Strattec Security Corp (STRT) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...
Strattec Security Corp (STRT) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...

Yahoo

time17 minutes ago

  • Yahoo

Strattec Security Corp (STRT) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...

Revenue Growth: 6% increase for the quarter and 5% for the fiscal year. Cash from Operations: $30 million for the quarter and $71 million for the fiscal year. Gross Margin Expansion: 370 basis points for the quarter and 280 basis points for the year. EBITDA Margin: 8.5% for the fourth quarter and 7.7% for the fiscal year. Gross Profit: Increased to $25.4 million for the fourth quarter. Operating Cash Flow: $30.2 million for the quarter, a 55% improvement over the same period last year. Free Cash Flow: $64.5 million for the fiscal year. Capital Expenditures: $7.2 million for the fiscal year. Cash Position: Ended the year with $84.6 million in cash. Available Credit Facilities: Approximately $52 million available. Warning! GuruFocus has detected 4 Warning Signs with CSAN. Release Date: August 15, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Strattec Security Corp (NASDAQ:STRT) ended fiscal 2025 with strong sales growth and expanded margins. The company generated $30 million in cash from operations for the quarter and $71 million for the fiscal year. Revenue grew 6% in the quarter and 5% for the year, driven by strategic pricing initiatives and higher demand. Gross margin expanded by 370 basis points for the quarter and 280 basis points for the year. The company has a healthy cash position of $84.6 million and approximately $52 million available under revolving credit facilities. Negative Points The company faces ongoing tariff expenses, with an estimated annual cost increase between $5 million to $7 million. Higher labor costs in Mexico are impacting the company's financials. The fiscal year 2026 is expected to see lower North American automotive production, potentially affecting sales. The company is still in the early stages of its transformation process, with long-term changes needed. There is uncertainty in the market, which may impact the company's ability to maintain its current cash flow levels. Q & A Highlights Q: How far along is Strattec in its transformation process, and what does the future look like for this initiative? A: Jennifer Slater, President and CEO, stated that Strattec is still in the early stages of its transformation. While they have addressed much of the low-hanging fruit in fiscal year 2025, future transformation efforts will be more long-term in nature. Q: Is Strattec considering exiting or divesting any product lines as part of its transformation? A: Jennifer Slater mentioned that Strattec is refocusing its engineering efforts on products with more growth potential, such as power access products and digital key fobs, rather than crowded markets like the switch product line. Q: What is the outlook for Strattec's gross margins in fiscal 2026? A: Matthew Pauli, CFO, indicated that while fiscal 2025 ended with a 15% gross margin, fiscal 2026 is expected to see revenues down to flattish. However, they anticipate tailwinds from pricing actions and restructuring efforts, balanced by inflationary pressures and volume headwinds. Q: How does Strattec plan to utilize its substantial cash reserves, and what is considered an appropriate cash cushion? A: Jennifer Slater explained that the company is comfortable with its current cash position, which provides stability amid market uncertainties. They are focusing on transforming the business and will consider cash allocation for shareholder value once there is more market certainty. Q: What are Strattec's plans for new product offerings or revenue opportunities in the next three to five years? A: Jennifer Slater stated that Strattec is focusing on expanding its customer base within its current product portfolio, particularly in power access and digital key products, while also exploring opportunities with new customers. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Sign in to access your portfolio

BioLargo Inc (BLGO) Q2 2025 Earnings Call Highlights: Strategic Moves Amid Revenue Challenges
BioLargo Inc (BLGO) Q2 2025 Earnings Call Highlights: Strategic Moves Amid Revenue Challenges

Yahoo

time17 minutes ago

  • Yahoo

BioLargo Inc (BLGO) Q2 2025 Earnings Call Highlights: Strategic Moves Amid Revenue Challenges

Release Date: August 15, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points BioLargo Inc (BLGO) has maintained its net stockholders' equity at around $6 million despite recent losses, showcasing effective capital management. The company has seen a significant increase in service revenues, rising from $300,000 to $1.2 million in the first half of the year. BioLargo Inc (BLGO) has successfully shipped its AEC unit to New Jersey, with validation work to be conducted by state and federal EPA, enhancing credibility. The company has raised $3.3 million in its subsidiary, Clyra Medical, indicating strong investor confidence in its potential. BioLargo Inc (BLGO) is pursuing a capital-conserving strategy by forming joint ventures for battery manufacturing, leveraging public funding and partnerships. Negative Points BioLargo Inc (BLGO) experienced a decline in revenue, with $3 million in the recent quarter compared to $5 million in the same period last year. The company faces uncertainty with its partner Ikigai and Pooph, impacting cash flow and financial forecasting. There is a significant delay in the commercialization of Clyra's wound care product, raising concerns about execution timelines. BioLargo Inc (BLGO) has increased debt obligations, primarily related to Clyra's preparation for product launch. The company is operating under financial pressure due to reduced cash flow from Pooph sales, necessitating cautious financial management. Q & A Highlights Warning! GuruFocus has detected 7 Warning Signs with BLGO. Q: Can you provide any additional insight into the challenges and successes to the barriers to entry for the salinity battery? A: Dennis Calvert, CEO, explained that the primary challenges include technical proof of claim, scaling up manufacturing, and regulatory hurdles. The company has achieved significant technical milestones and is working on scaling up production. Regulatory barriers are relatively low, focusing mainly on safety data and UL certification. The company is confident in its technology and is working towards proving its claims and securing partnerships. Q: Will BioLargo be funding the cost to build battery factories? Will you be involved in designing and building the factories? A: Dennis Calvert, CEO, stated that BioLargo will not be funding the factories directly. Instead, they will act as a vendor, providing engineering services, project management, and technology transfer. The factories will be financed through partnerships, public funding, and other financial arrangements, allowing BioLargo to focus on leveraging its core competencies. Q: What is the latest on New Jersey and the AEC project? A: Dennis Calvert, CEO, reported that the AEC unit has been shipped and is being set up in Lake Stockholm. The state and federal EPA will participate in validation work, which is crucial for future customer demonstrations. The company is excited about this significant milestone and will announce the go-live date soon. Q: How can you be so confident about Clyra given that it's taken so long? A: Dennis Calvert, CEO, expressed confidence in Clyra due to recent investments of $3.3 million and the technical prowess of their invention. The company is preparing for a significant product launch with strong partnerships in place. They aim to complete third-party testing and FDA paperwork by the end of the year, targeting a Q1 launch. Q: Do you have insight on Pooph's operations as far as advertising spend, the number of stores that they're in? A: Dennis Calvert, CEO, mentioned limited insight into Pooph's operations, making it difficult to forecast. However, he noted that Pooph had previously achieved a $50 million run rate and was in 40,000 stores. The company remains optimistic about Pooph's potential but is cautious due to uncertainties. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store